for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Navidea Announces Positive Results Of Second Interim Analysis Of Ongoing Phase 2B Study In Rheumatoid Arthritis

May 21 (Reuters) - Navidea Biopharmaceuticals Inc:

* NAVIDEA BIOPHARMACEUTICALS ANNOUNCES POSITIVE RESULTS OF SECOND INTERIM ANALYSIS OF ONGOING PHASE 2B STUDY IN RHEUMATOID ARTHRITIS

* NAVIDEA BIOPHARMACEUTICALS - DATA SUPPORT HYPOTHESIS THAT TC99M TILMANOCEPT IMAGING CAN PROVIDE EARLY INDICATOR OF TREATMENT RESPONSE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up